| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Preclinical Research, Sandoz Pharma LTD, CH-4002 Basle, Switzerland
The somatostatin analogue octreotide (SMS 201-995) inhibits secretion and growth of certain tumor cells, and current efforts are directed toward the elucidation of its mode of antiproliferative action. In this study, the effect of octreotide on the growth of ZR-75-1 human breast cancer cells has been characterized in immunodeficient nude mice and in cell culture. These results have been related to the expression of somatostatin receptors in vivo and in vitro. Continuous infusion of 10 µg/kg/h of octreotide yielded plasma levels of 5.7 ng/ml and elicited highly significant growth inhibitory effects on solid ZR-75-1 breast tumors in nude mice. After 2 and 4 weeks of treatment, tumor volumes in the octreotide group were 39.1 and 36.7% of those of control animals treated with vehicle, respectively. Autoradiographic studies demonstrated that 8 of 12 ZR-75-1 tumors studied were somatostatin receptor positive. When ZR-75-1 tumor cells were exposed in vitro to nanomolar concentrations of octreotide, a dose-dependent inhibition of cell growth was observed in the presence of 5% fetal calf serum or under serum-free conditions using epidermal growth factor, insulin-like growth factor type I, or insulin as growth stimulus. In parallel receptor-binding experiments, ZR-75-1 cells were shown to express specific high-affinity somatostatin receptors (Kd value = 0.9 nM, Bmax = 6000 sites/cell). From these experiments, we conclude that octreotide is a powerful inhibitor of ZR-75-1 tumor cell growth in nude mice and in culture. This inhibitory action of octreotide and the presence of somatostatin receptors on ZR-75-1 tumor cells in vitro and in vivo suggest a direct, somatostatin receptor-mediated effect of octreotide.
1 To whom requests for reprints and correspondence should be addressed.
Received 2/19/92. Accepted 7/ 7/92.
This article has been cited by other articles:
|
|
 |
|
  E. Peverelli, G. Mantovani, D. Calebiro, A. Doni, S. Bondioni, A. Lania, P. Beck-Peccoz, and A. Spada The Third Intracellular Loop of the Human Somatostatin Receptor 5 Is Crucial for Arrestin Binding and Receptor Internalization after Somatostatin Stimulation Mol. Endocrinol., March 1, 2008; 22(3): 676 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Siriwardana, A. Bradford, D. Coy, and P. Zeitler Autocrine/Paracrine Regulation of Breast Cancer Cell Proliferation by Growth Hormone Releasing Hormone via Ras, Raf, and Mitogen-Activated Protein Kinase Mol. Endocrinol., September 1, 2006; 20(9): 2010 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Filosso, E. Ruffini, A. Oliaro, O. Rena, C. Casadio, M. Mancuso, D. Turello, R. C. Cristofori, and G. Maggi Large-cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 819 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Faiss, U.-F. Pape, M. Bohmig, Y. Dorffel, U. Mansmann, W. Golder, E. O. Riecken, and B. Wiedenmann Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors--The International Lanreotide and Interferon Alfa Study Group J. Clin. Oncol., July 15, 2003; 21(14): 2689 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Slooter, A. G.J. Aalbers, W. A.P. Breeman, C. A. Hiemstra, R. L. Marquet, E. P. Krenning, and C. H.J. van Eijck The Inhibitory Effect of 111In-DTPA0-Octreotide on Intrahepatic Tumor Growth After Partial Hepatectomy J. Nucl. Med., December 1, 2002; 43(12): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yoshida, T. Ishibashi, and M. Nishio Growth-inhibitory Effect of a Streptococcal Antitumor Glycoprotein on Human Epidermoid Carcinoma A431 Cells: Involvement of Dephosphorylation of Epidermal Growth Factor Receptor Cancer Res., August 1, 2001; 61(16): 6151 - 6157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, H. Zheng, and M. Hauer-Jensen Influence of Short-Term Octreotide Administration on Chronic Tissue Injury, Transforming Growth Factor {beta} (TGF-{beta}) Overexpression, and Collagen Accumulation in Irradiated Rat Intestine J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 35 - 42. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schulz, S. U. Pauli, S. Schulz, M. Händel, K. Dietzmann, R. Firsching, and V. Höllt Immunohistochemical Determination of Five Somatostatin Receptors in Meningioma Reveals Frequent Overexpression of Somatostatin Receptor Subtype sst2A Clin. Cancer Res., May 1, 2000; 6(5): 1865 - 1874. [Abstract] [Full Text]
|
|
|
|
|
|
B. E. Rogers, S. F. McLean, R. L. Kirkman, D. Della Manna, S. J. Bright, C. C. Olsen, A. D. Myracle, M. S. Mayo, D. T. Curiel, and D. J. Buchsbaum In Vivo Localization of [111In]-DTPA-D-Phe -Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector Clin. Cancer Res., February 1, 1999; 5(2): 383 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Benlot, L. Levy, P. Fontanaud, A. Roche, P. Rouannet, and D. Joubert Somatostatin and Growth Hormone-Releasing Hormone in Normal and Tumoral Human Breast Tissue: Endogenous Content, in Vitro Pulsatile Release, and Regulation J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 690 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wangberg, O. Nilsson, V. Johanson, L. Kolby, E. Forssell-Aronsson, P. Andersson, M. Fjalling, L.-E. Tisell, and H. Ahlman Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumors Oncologist, February 1, 1997; 2(1): 50 - 58. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
